Diarrhea News and Research

Latest Diarrhea News and Research

Creighton researcher to study role of adult stem cells in repairing damaged coronary arteries

A Creighton University School of Medicine researcher has received a $3.3 million, five-year grant from the National Institutes of Health to study what role adult stem cells might play in repairing damaged coronary arteries, a complication that often occurs in patients after they undergo angioplasty and stenting.

24 Jan 2012

Pakistan's polio eradication program facing challenges after increase in cases last year

IRIN examines several factors that could be contributing to an increase in polio cases in Pakistan, "despite the launch of a National Emergency Action Plan for Polio Eradication" at the beginning of 2011. In 2010, Pakistan recorded 144 cases of polio and 192 cases in 2011, the news service reports.

24 Jan 2012

Takeda receives FDA approval for VELCADE sNDA to treat MM

Millennium: The Takeda Oncology Company with its parent company Takeda Pharmaceutical Company Limited today announced that the U.S. Food and Drug Administration (FDA) has approved a supplemental new drug application (sNDA) for VELCADE(bortezomib), which updates the label to include the subcutaneous method of administration in all approved indications: multiple myeloma and mantle cell lymphoma after at least one prior therapy.

24 Jan 2012

EMA CHMP issues positive opinion to MSD's REMICADE for treatment of pediatric UC

MSD today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) adopted a positive opinion recommending the use of REMICADE (infliximab) in the treatment of severely active ulcerative colitis (UC) in pediatric patients ages 6 to 17 years, who have had an inadequate response to conventional therapy, including corticosteroids and 6-mercaptopurine or azathioprine, or who are intolerant to or have medical contraindications for such therapies.

21 Jan 2012

Positive preliminary data from Exelixis' cabozantinib phase 2 trial on HCC

Exelixis, Inc. today reported positive preliminary data from the cohort of hepatocellular carcinoma (HCC) patients participating in the ongoing phase 2 randomized discontinuation trial (RDT) of cabozantinib.

20 Jan 2012

Experimental drug helps patients with advanced colon cancer

According to results from a new clinical trial, an experimental cancer drug regorafenib appears to extend survival slightly in patients with metastatic colorectal cancer. Regorafenib is a so-called multikinase inhibitor, which targets several of the ways cancer develops and grows, researchers said.

19 Jan 2012

Study demonstrates possibility of curing hepatitis C without use of interferon

Bristol-Myers Squibb Company today announced the full results, published in the New England Journal of Medicine, from a Phase II clinical trial in patients with hepatitis C virus (HCV) genotype 1 who had not responded to prior therapy with PEG-interferon alfa and ribavirin ('null responders').

19 Jan 2012

New combo drug helps suppress hepatitis C genotype 1 infection

A new combination of investigational drugs successfully suppressed hepatitis C genotype 1 infection in a high percent of patients who had not responded to previous treatment in a study led by a University of Michigan hepatologist.

19 Jan 2012

Gilead Sciences receives FDA approval for Viread to treat pediatric HIV infection

Gilead Sciences, Inc. announced today that the U.S. Food and Drug Administration (FDA) has approved Viread in combination with other antiretroviral agents for the treatment of HIV-1 infection in pediatric patients ages 2-12.

19 Jan 2012

ViroPharma's NDS for Cinryze receives Health Canada's Priority Review status

ViroPharma Incorporated today announced that Health Canada has granted the company Priority Review status for its New Drug Submission (NDS) for Cinryze (C1 inhibitor [human]).

13 Jan 2012

Investing in Frontline Health Workers effective in saving lives of mothers, children

In the Huffington Post's "Impact" blog, Carolyn Miles, president and CEO of Save the Children, writes about the Frontline Health Workers Coalition's call on the U.S. government to train 250,000 new frontline health workers in developing countries, stating, "At a time when every dollar counts more than ever, the new Frontline Health Workers Coalition believes this focus is the most cost-effective way to save mothers' and children's lives around the world, address global health threats, and help advance strategic U.S. interests in a secure and prosperous world."

12 Jan 2012

Low-voltage alternating current can effectively eradicate E. coli on beef

A short burst of low voltage alternating current can effectively eradicate E. coli bacteria growing on the surface of even heavily contaminated beef, according to a study published in the International Journal of Food Safety, Nutrition and Public Health. The technique offers an inexpensive and easy to implement approach to reducing the risk of food poisoning, which can occur despite handlers complying with hygiene standards.

12 Jan 2012

Aid group tracks down likely first case in Haiti's cholera outbreak

"A mentally ill man who bathed in and drank from a contaminated river most likely was the first person to be infected" with cholera in the outbreak that began in Haiti in October 2010, researchers from Partners in Health said in a study published Monday in the American Journal of Tropical Medicine and Hygiene, the Associated Press/Washington Post reports (1/9).

11 Jan 2012

Modified probiotics could one day decrease risk of Listeria infection

Modified probiotics, the beneficial bacteria touted for their role in digestive health, could one day decrease the risk of Listeria infection in people with susceptible immune systems, according to Purdue University research.

10 Jan 2012

Stimflora launches new dietary health product

An exciting new dietary health product has been launched which promotes healthy digestion while strengthening the immune system.

7 Jan 2012

IRIN examines risk of waterborne diseases in Zimbabwe

IRIN examines how a lack of sanitation facilities and access to clean water, as well as the onset of the rainy season, are increasing the risk of waterborne diseases in rural areas of Zimbabwe.

6 Jan 2012

Bringing health solutions to women, children

In this Huffington Post "Impact" blog post, Melinda Gates, co-chair of the Bill & Melinda Gates Foundation, writes that she will be visiting Bangladesh to "learn even more about two of the biggest killers of children -- pneumonia and diarrhea," and says "Bangladesh has made incredible progress in recent years, reducing the number of childhood deaths by 65 percent since 1990."

6 Jan 2012

Re-introduction of rotavirus vaccine does not increase intussusception rates in the U.S.

The rotovirus vaccine was pulled from the marketplace in 1999 after being associated with painful gastrointestinal complications, however, the updated rotavirus vaccines do not appear to increase the occurrence of these potentially fatal side effects, according to a new study by child health experts at C.S. Mott Children's Hospital.

5 Jan 2012

Study finds increase in incidence and prevalence of IBD

The incidence and prevalence of inflammatory bowel disease (IBD) are increasing with time and in different regions around the world, according to a new study in Gastroenterology, the official journal of the American Gastroenterological Association.

5 Jan 2012

FDA approves CSL Behring's Berinert for treatment of HAE attacks

CSL Behring today announced that the U.S. Food and Drug Administration (FDA) has approved a label expansion for self-administration of Berinert, C1 Esterase Inhibitor (Human), a pasteurized, nanofiltered therapy indicated for the treatment of acute attacks of hereditary angioedema (HAE), a rare and potentially fatal genetic disorder.

4 Jan 2012